You have 9 free searches left this month | for more free features.

recurrent pituitary tumor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Pituitary Adenomas Trial in New York (Capecitabine, Temozolomide)

Terminated
  • Recurrent Pituitary Adenomas
  • New York, New York
    Weill Cornell Medical College
Jul 15, 2022

Acromegaly Due to Pituitary Adenoma Trial in Copenhagen (GIP-A, Placebo)

Recruiting
  • Acromegaly Due to Pituitary Adenoma
  • GIP-A
  • Placebo
  • Copenhagen, Denmark
    Department of Biomedical Sciences
Nov 1, 2022

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Pituitary Tumor Trial in Phoenix, Cleveland (Nasal saline irrigation)

Recruiting
  • Pituitary Tumor
  • Nasal saline irrigation
  • Phoenix, Arizona
  • +1 more
Dec 19, 2022

Clinically Nonfunctioning Pituitary Adenomas

Recruiting
  • Pituitary Adenoma
  • Pituitary Tumor
  • Surgical intervention for CNFA
  • Radiotherapy for CNFA
  • New York, New York
    Columbia University Vagelos College of Physicians & Surgeons
Oct 24, 2022

Pituitary Adenoma Trial in Nantong (Excision of pituitary tumor outside pseudocapsule)

Not yet recruiting
  • Pituitary Adenoma
  • Excision of pituitary tumor outside pseudocapsule
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Jul 19, 2022

Pituitary Adenoma, Pituitary Tumor, Diabetes Insipidus Cranial Type Trial in Leiden (Micro-electrode measurement)

Recruiting
  • Pituitary Adenoma
  • +3 more
  • Micro-electrode measurement
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 13, 2022

Hypopituitarism, Radiotherapy-Induced Hypopituitarism, Brain Tumor Trial in Dublin (Dynamic testing of Pituitary Function)

Not yet recruiting
  • Hypopituitarism
  • +2 more
  • Dynamic testing of Pituitary Function
  • Dublin, Ireland
  • +1 more
Aug 22, 2023

Pituitary Tumor Surveillance: Pathogenic Correlation

Recruiting
  • Pituitary Tumor
    • Los Angeles, California
      Cedars-Sinai Medical Center, Pituitary Center
    Aug 23, 2021

    Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

    Recruiting
    • Solid Tumor
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    May 31, 2023

    Pituitary Tumor, Blood Loss, Surgery Trial (Tranexamic acid, Placebo)

    Withdrawn
    • Pituitary Tumor
    • +2 more
    • Tranexamic acid
    • Placebo
    • (no location specified)
    Mar 25, 2022

    Molecular Study and Precision Medicine for Colorectal Cancer

    Not yet recruiting
    • Advanced Colorectal Carcinoma
    • Recurrent Colorectal Carcinoma
    • Molecular Profiling & drug testing in tumor organoids and PDXs
    • Wuhan, Hubei, China
      Wuhan Union Hospital, China
    May 30, 2023

    Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Giant Cell Glioblastoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Jan 4, 2023

    Tumor Rebiopsy in Children and Recurrent or Progressive Solid

    Active, not recruiting
    • Tumor, Solid
    • Re-biopsy
    • Questionnaire
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 10, 2022

    Solid Tumors, Adult Trial (tumor treatment vaccine injection)

    Not yet recruiting
    • Solid Tumors, Adult
    • tumor treatment vaccine injection
    • (no location specified)
    Feb 16, 2023

    International PPB/DICER1 Registry

    Recruiting
    • Pleuropulmonary Blastoma
    • +14 more
      • Minneapolis, Minnesota
        Children's Minnesota
      Aug 16, 2022

      Glioblastoma, Glioblastoma, IDH-wildtype Trial in Rome (Biomolecular tumor analysis)

      Recruiting
      • Glioblastoma
      • Glioblastoma, IDH-wildtype
      • Biomolecular tumor analysis
      • Rome, Italy
        Fondazione Policlinico Universitario A. Gemelli IRCCS
      Mar 6, 2023

      Brain Tumor, Primary, Meningioma, Schwannoma Trial in Seoul

      Recruiting
      • Brain Tumor, Primary
      • +4 more
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Feb 14, 2022

        Endometrial Cancer, Endometrioid Tumor, Cancer Trial in Oklahoma City (nab-sirolimus)

        Not yet recruiting
        • Endometrial Cancer
        • +5 more
        • Oklahoma City, Oklahoma
          University Oklahoma Stephenson Cancer Center
        Aug 16, 2023

        Pituitary Tumor, ACTH-producing Pituitary Tumour Trial in New York (Pasireotide LAR)

        Terminated
        • Pituitary Tumor
        • ACTH-producing Pituitary Tumour
        • Pasireotide LAR
        • New York, New York
          Neuroendocrine Unit and Pituitary Center, Columbia University
        Mar 31, 2021

        HER2-positive Recurrent or Metastatic Malignant Solid Tumor Trial in Zhengzhou (Recombinant Humanized Bispecific Monoclonal

        Recruiting
        • HER2-positive Recurrent or Metastatic Malignant Solid Tumor
        • Recombinant Humanized Bispecific Monoclonal Antibody MBS301
        • Zhengzhou, China
          Henan Cancer Hospital
        Nov 9, 2022

        Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

        Recruiting
        • Refractory Cancer
        • +14 more
        • Atlanta, Georgia
        • +1 more
        Oct 23, 2023

        CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

        Active, not recruiting
        • Central Nervous System Tumor, Pediatric
        • +8 more
        • EGFR806-specific chimeric antigen receptor (CAR) T cell
        • Seattle, Washington
          Seattle Children's Hospital
        Jan 18, 2023

        Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

        Recruiting
        • Recurrent Solid Tumor
        • +21 more
        • Palo Alto, California
        • +8 more
        Jun 7, 2022